Results 231 to 240 of about 128,678 (309)

Apical Hypertrophic Cardiomyopathy: A Rare and Hidden Cause of Stroke. [PDF]

Cureus
Stringer I, Patel A, Edhem L, Delamere R, Eni G, Ahmed A, Solano J.   +6 more
europepmc   +1 more source

First-pass Myocardial Perfusion Defect and Delayed Contrast Enhancement in Hypertrophic Cardiomyopathy Assessed with MRI

, 2003
Tsuyoshi Matsunaka, Mareomi Hamada, Yuji Matsumoto, Jitsuo Higaki   +3 more
openalex   +2 more sources

Social Determinants of Health and Clinical Outcomes in Hypertrophic Cardiomyopathy.

JAMA Cardiol
Hafeez N, Claggett BL, Owens AT, Helms AS, Saberi S, Lampert R, Stendahl JC, Ashley EA, Parikh VN, Lakdawala NK, Ingles J, Olivotto I, Ho CY, Taylor MR, Khan SS, Day SM.   +15 more
europepmc   +1 more source

Isolated Right Ventricular Hypertrophic Cardiomyopathy Mimicking an Intramural Mass in a 13-Year-Old Male. [PDF]

Clin Case Rep
Tingting H, Guotao M, Xiaona L, Ximin S, Yongtai L.   +4 more
europepmc   +1 more source

Rationale, Objectives and Study Design of the Taiwan Registry of Hypertrophic Cardiomyopathy (THIC). [PDF]

Acta Cardiol Sin
Wu YW, Yu WC, Hung CL, Lai CH, Wang CY, Lin CC, Juang JJ, Huang CY, Chen PS, Ko TY, Chang WT, Tseng H, Chen ZW, Chu CY, Chen WJ, Li YH.   +15 more
europepmc   +1 more source

MAVACAMTEN REDUCES ECHO-DOPPLER DERIVED PULMONARY ARTERY SYSTOLIC PRESSURE IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY PATIENTS WITH ELEVATED PULMONARY ARTERY SYSTOLIC PRESSURE AT BASELINE

M Gegenava, Morgane Herry, Chun‐Tai Mao, M. Roselle Abraham, Theodore P. Abraham   +4 more
openalex   +1 more source

ODYSSEY-HCM trial (mavacamten in symptomatic nonobstructive hypertrophic cardiomyopathy). [PDF]

Eur Heart J Cardiovasc Pharmacother
Monda E, Limongelli G.
europepmc   +1 more source

Genotype-Phenotype Relationship in Hypertrophic Cardiomyopathy. [PDF]

Genes (Basel)
Žebrauskienė D, Sadauskienė E, Puronaitė R, Masiulienė R, Vaišnorė R, Bratčikovienė N, Valevičienė N, Barysienė J, Jakaitienė A, Preikšaitienė E.   +9 more
europepmc   +1 more source

Low-Dose Mavacamten Initiation in Obstructive Hypertrophic Cardiomyopathy: A Real-World Study in China. [PDF]

Cardiovasc Ther
Yang W, Shi H, Chang RS, Zhang Y, Jixiang A, Wu C, Qian J, Ge J, Zhang S.   +8 more
europepmc   +1 more source

OR1-28 | Comparison of In-Hospital Outcomes Between Hypertrophic Obstructive Cardiomyopathy and Non-Obstructive Hypertrophic Cardiomyopathy Among Patients Hospitalized for Cardiogenic Shock: A Nationwide Analysis

Amir Joshi, Shreyash Parajuli, Vidit Majmundar, Sushil Rayamajhi, Kannu Bansal, Ramses Thabet   +5 more
openalex   +1 more source